Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Statins for primary prevention of coronary artery disease.

Reidenberg MM.

Lancet. 2007 Mar 31;369(9567):1078; author reply 1079. No abstract available.

PMID:
17398297
2.

High-density lipoprotein-dependent effects of statins on the risk of coronary heart disease deaths and events.

Takagi H, Matsui M, Umemoto T.

Int J Cardiol. 2011 Nov 3;152(3):377-9. doi: 10.1016/j.ijcard.2011.07.071. Epub 2011 Aug 17. Review. No abstract available.

PMID:
21851993
3.

Statins for primary prevention of coronary artery disease.

McPherson R, Kavaslar N.

Lancet. 2007 Mar 31;369(9567):1078; author reply 1079. No abstract available.

PMID:
17398299
4.

Diabetic dyslipidemia: a practical guide to therapy.

Tovar JM, Bazaldua OV, Loffredo A.

J Fam Pract. 2008 Jun;57(6):377-88.

PMID:
18544321
5.

Statins for primary prevention of coronary artery disease.

Mascitelli L, Pezzetta F.

Lancet. 2007 Mar 31;369(9567):1078-9; author reply 1079. No abstract available.

PMID:
17398298
6.

Ongoing clinical trials of statins.

Gotto AM Jr.

Am J Cardiol. 2001 Aug 16;88(4A):36F-40F. Review.

PMID:
11520486
8.

Statins in the prevention of transplant coronary artery disease: in pediatric heart recipients.

Pahl E.

Pediatr Transplant. 2007 Aug;11(5):459-60. No abstract available.

PMID:
17631010
9.

[Cholesterol-reducing therapy of arteriosclerosis].

Mabudhi H.

Nihon Naika Gakkai Zasshi. 1998 Mar 10;87(3):540-7. Review. Japanese. No abstract available.

PMID:
9577590
10.

Primary prevention and statins: is it just about going to class?

Krasuski RA.

Mayo Clin Proc. 2008 Dec;83(12):1313-5. doi: 10.1016/S0025-6196(11)60778-7. No abstract available.

PMID:
19046549
11.

The case for statins: has it really been made?

Thompson A, Temple NJ.

J R Soc Med. 2004 Oct;97(10):461-4. No abstract available.

12.

Statins for primary prevention: strategic options to save lives and money.

Shepherd J.

J R Soc Med. 2004 Feb;97(2):66-71. Review. No abstract available.

13.

Lessons learned from statin trials.

Auer J, Berent R, Eber B.

Clin Cardiol. 2001 Apr;24(4):277-80. Review.

14.

Low-density lipoprotein-dependent and independent effects of statins on prevention of major coronary events: meta-regression of randomized placebo-controlled trials.

Takagi H, Umemoto T; All-Literature Investigation of Cardiovascular Evidence (ALICE) Group.

Int J Cardiol. 2013 Oct 12;168(5):4850-3. doi: 10.1016/j.ijcard.2013.07.067. Epub 2013 Jul 25. No abstract available.

PMID:
23890857
15.

Statins for primary cardiovascular prevention.

Seehusen DA.

Am Fam Physician. 2011 Oct 1;84(7):767-8. No abstract available.

16.

Where to draw the line using statins: lessons from 4S to AFCAPS/TexCAPS.

Sprecher DL.

Cleve Clin J Med. 2000 Mar;67(3):169-71. No abstract available.

PMID:
10743305
17.

Statins, cholesterol, and the prevention of coronary heart disease.

Freeman MW.

FASEB J. 2006 Feb;20(2):200-1. No abstract available.

PMID:
16449790
18.

Therapy and clinical trials.

Smith MR, Elkeles RS.

Curr Opin Lipidol. 1999 Aug;10(4):379-81. No abstract available.

PMID:
10482143
19.

Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?

Kakafika AI, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP.

Expert Opin Pharmacother. 2008 Jun;9(9):1437-40. doi: 10.1517/14656566.9.9.1437 .

PMID:
18518775
20.

Statin therapy in older persons: pertinent issues.

Grundy SM.

Arch Intern Med. 2002 Jun 24;162(12):1329-31. No abstract available.

PMID:
12076230

Supplemental Content

Support Center